Oncimmune Holdings plc (LON:ONC – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 17.45 ($0.23) and traded as low as GBX 14.60 ($0.19). Oncimmune shares last traded at GBX 14.79 ($0.19), with a volume of 318,211 shares traded.
Oncimmune Stock Performance
The stock has a market cap of £10.97 million, a P/E ratio of -493.00 and a beta of 1.19. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85. The business has a 50 day moving average price of GBX 17.45 and a two-hundred day moving average price of GBX 17.26.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Featured Articles
- Five stocks we like better than Oncimmune
- Find and Profitably Trade Stocks at 52-Week Lows
- Texas Roadhouse Stock Steering for New Highs This Year
- What is the S&P 500 and How It is Distinct from Other Indexes
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What Are the FAANG Stocks and Are They Good Investments?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
